Interleukin 5 (IL-5) is a key cytokine in the regulation of eosinophilia and eosinophil activation in humans. Monoclonal antibodies to anti-IL-5 have become available for use in clinical studies in humans. This article discusses the rationale for the use of anti-IL-5 therapy in asthma and hypereosinophilic syndrome and summarizes the available clinical data on the use of anti-IL-5 to treat these disorders.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.iac.2004.06.007 | DOI Listing |
Publication Analysis
Top Keywords
therapy asthma
8
asthma hypereosinophilic
8
hypereosinophilic syndrome
8
anti-interleukin-5 therapy
4
syndrome interleukin
4
interleukin il-5
4
il-5 key
4
key cytokine
4
cytokine regulation
4
regulation eosinophilia
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!